The History of Polio and Vaccine Development

Polio, short for poliomyelitis, was once one of the most feared diseases globally, causing paralysis and death, particularly among children. The development of polio vaccines in the 1950s marked a turning point in medical history. Dr. Jonas Salk introduced the first successful polio vaccine in 1955, followed by Dr. Albert Sabin's oral vaccine in 1961. These breakthrough developments began what would become one of the most successful vaccination campaigns in history, reducing global polio cases by 99.9% since the 1980s.

The disease primarily affected children under five years old, causing irreversible paralysis in one out of every 200 infections. Before vaccines became available, polio outbreaks caused widespread panic, leading to the closure of swimming pools, movie theaters, and other public spaces. The iron lung, a mechanical respirator that helped patients breathe, became a symbol of the polio era, representing both the severity of the disease and humanity's determination to fight it.

Types of Polio Vaccines

There are two main types of Polio Vaccines currently in use worldwide: the Inactivated Polio Vaccine (IPV) and the Oral Polio Vaccine (OPV). Each has its unique characteristics and applications in different healthcare settings.

The Inactivated Polio Vaccine (IPV), developed by Jonas Salk, contains killed poliovirus strains. It's administered through injection and provides excellent protection against all three poliovirus types. IPV is the only polio vaccine that has been used in the United States since 2000. It cannot cause vaccine-derived poliovirus (VDPV) and is considered extremely safe.

The Oral Polio Vaccine (OPV), created by Albert Sabin, contains weakened live poliovirus strains. It's administered orally through drops and is still widely used in many developing countries. OPV is less expensive than IPV and easier to administer, making it particularly suitable for mass vaccination campaigns. It also provides intestinal immunity, which helps prevent the spread of wild poliovirus.

How Polio Vaccines Work?

Polio vaccines work by stimulating the immune system to produce antibodies against poliovirus. When a vaccinated person is exposed to the actual virus, their immune system recognizes it and responds quickly to prevent infection. This process, known as active immunity, provides long-lasting protection against the disease.

IPV works by introducing killed virus particles into the body, which cannot cause infection but still trigger an immune response. The vaccine requires multiple doses to achieve optimal protection, typically administered at two months, four months, 6-18 months, and 4-6 years of age.

OPV contains weakened live viruses that replicate in the intestine, producing stronger intestinal immunity than IPV. The vaccine virus is shed in stool and can spread to others in areas with poor sanitation, potentially immunizing additional people. However, this characteristic also carries a small risk of vaccine-derived poliovirus, particularly in areas with low vaccination coverage.

Safety and Effectiveness

Both polio vaccines have proven to be extremely safe and effective over decades of use. IPV has no risk of vaccine-derived poliovirus and causes only mild side effects, such as soreness at the injection site. It's considered one of the safest vaccines available.

OPV's safety profile is also strong, though it carries a very small risk (about 1 in 2.7 million doses) of vaccine-associated paralytic poliomyelitis (VAPP). This risk has led many developed countries to switch exclusively to IPV, while OPV remains crucial in global eradication efforts due to its cost-effectiveness and ease of administration.

The effectiveness of both vaccines is remarkable. When administered according to recommended schedules, they provide nearly 100% protection against paralytic polio. This high efficacy has been demonstrated through dramatic reductions in polio cases worldwide.

Global Eradication Efforts

The Global Polio Eradication Initiative (GPEI), launched in 1988, represents one of the largest public health initiatives in history. Through coordinated vaccination campaigns, surveillance, and community engagement, polio cases have decreased from an estimated 350,000 cases in 1988 to just a handful of cases in recent years.
 

Get more insights on, Polio Vaccines

Get This Report in Japanese Language: ポリオ・ワクチン

Get This Report in Korean Language: 소아마비 백신

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)